biopharmaceutical considerations and physiochemical foundation of various dosage forms

The topic is about “biopharmaceutical and physicochemical considerations” for different dosage forms — basically how the drug’s properties and the body’s biology affect how a medicine works.

Biopharmaceutical considerations



 First, Understand the Two Key Words:

1. Biopharmaceutical Considerations

This means — how the drug behaves inside the body after you take it.
Like:

  • How it is absorbed (goes into the blood)
  • How it is distributed (moves around the body)
  • How it is metabolized (broken down)
  • How it is excreted (removed)

Basically, how the dosage form affects the bioavailability (how much drug actually reaches the bloodstream and works).


2. Physicochemical Considerations

This means — how the drug’s physical and chemical properties affect its formulation.
Like:

  • Solubility 💧
  • Particle size 🔹
  • pH and stability ⚖️
  • Polymorphism (crystal forms) 💎
  • Partition coefficient (lipid/water solubility balance)

These factors decide which dosage form is suitable and how stable and effective it’ll be.


Now let’s look at each dosage form, one by one 👇


🧪 1. Solutions

Definition: Drug completely dissolved in a solvent (like syrup, oral solution, or eye drop).
Physicochemical factors:

  • Solubility is most important.
  • pH and temperature affect stability.
  • Preservatives are added to prevent microbial growth.

Biopharmaceutical point:

  • Fastest absorption because drug is already dissolved.
  • Good for quick action and easy swallowing.

🌫️ 2. Powders

Definition: Dry, solid mixture of finely divided drugs.
Physicochemical factors:

  • Particle size affects dissolution and absorption.
  • Moisture can cause clumping or degradation.

Biopharmaceutical point:

  • Absorption depends on how fast it dissolves in GI fluids.
  • Used when stability in liquid form is poor.

💧 3. Colloids

Definition: Very small particles (1–1000 nm) dispersed in another medium (like gels, sols).
Physicochemical factors:

  • Surface charge and particle size matter.
  • Stability is maintained by preventing aggregation.

Biopharmaceutical point:

  • Improves absorption by increasing surface area.
  • Can enhance drug targeting and control release.

🌪️ 4. Dispersions

Definition: Systems where one phase is dispersed in another (solid in liquid, etc.).
Example: suspensions, emulsions.
Physicochemical factors:

  • Uniform particle size distribution.
  • Proper viscosity and stability needed.

Biopharmaceutical point:

  • Drug must dissolve from dispersed phase before absorption.
  • Rate of absorption depends on particle size.

🥛 5. Emulsions

Definition: Mixture of oil and water phases stabilized by an emulsifier.
Physicochemical factors:

  • Type (O/W or W/O) depends on drug solubility.
  • Surfactants maintain stability.

Biopharmaceutical point:

  • Improves absorption of poorly water-soluble drugs.
  • Can mask taste and reduce irritation.

🧴 6. Semisolids

Definition: Creams, gels, ointments — applied to skin.
Physicochemical factors:

  • Base type (hydrophilic/hydrophobic) affects drug release.
  • Viscosity affects spreadability and absorption.

Biopharmaceutical point:

  • Drug must penetrate skin layers.
  • Used for local or transdermal delivery.

🌡️ 7. Suppositories

Definition: Solid dosage form inserted into rectum, vagina, or urethra.
Physicochemical factors:

  • Base should melt at body temperature.
  • Uniform drug distribution is important.

Biopharmaceutical point:

  • Useful for patients who can’t take oral drugs.
  • Bypasses first-pass metabolism (rectal route).

💊 8. Tablets

Definition: Compressed solid form containing drug + excipients.
Physicochemical factors:

  • Disintegration and dissolution rates are key.
  • Proper hardness and friability.

Biopharmaceutical point:

  • Drug release depends on formulation (immediate or controlled).
  • Common, stable, easy to handle form.

🧫 9. Capsules

Definition: Drug enclosed in gelatin shell (hard or soft).
Physicochemical factors:

  • Drug must dissolve in GI fluids after shell breaks.
  • Moisture content affects shell stability.

Biopharmaceutical point:

  • Better patient compliance (easy to swallow).
  • Useful for oily or bad-tasting drugs.

💉 10. Injectables (Parenterals)

Definition: Sterile liquid or suspension injected into body (IV, IM, SC).
Physicochemical factors:

  • Must be sterile and pyrogen-free.
  • pH and tonicity should match body fluids.

Biopharmaceutical point:

  • Gives rapid and complete absorption (especially IV).
  • Used for emergency or when oral route not possible.

🩹 11. Topicals

Definition: Applied to skin for local effect (creams, lotions, ointments).
Physicochemical factors:

  • Base type affects release and absorption.
  • Stability against oxidation and light.

Biopharmaceutical point:

  • Drug should pass through skin barrier for effect.
  • Localized action with minimal systemic side effects.

🩼 12. Patches (Transdermal Systems)

Definition: Adhesive patches that deliver drug through skin into blood.
Physicochemical factors:

  • Drug must be lipophilic and small enough to cross skin.
  • Polymer matrix controls release rate.

Biopharmaceutical point:

  • Provides controlled and sustained release.
  • Avoids first-pass metabolism.

🌬️ 13. Inhalation Devices

Definition: Used for delivering drug directly to lungs (MDI, DPI, nebulizers).
Physicochemical factors:

  • Particle size (1–5 µm) critical for reaching alveoli.
  • Propellant and formulation stability matter.

Biopharmaceutical point:

  • Fast onset, direct action on lungs.
  • Used in asthma, COPD, etc
ALSO VISIT :-> Pharmaceutical drug delivery Systems

Post a Comment

Apna pharma empowering health and wellness through our Personalized Care and Guidance Making Our Country Safe and vigilant

Previous Post Next Post
Subscribe Apna pharma !